English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 感染症 > インドネシアにおけるB型肝炎治療に関する機会アセスメント
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

インドネシアにおけるB型肝炎治療に関する機会アセスメント

Opportunities Assessment for Hepatitis B Therapeutics Market in Indonesia

発行 Frost & Sullivan
出版日 2009年03月 商品コード 83700
ページ情報 英文 36 Pages
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This research service aims to provide an update on the epidemiology of hepatitis B, current diagnostic and treatment practices, as well as market landscape in terms of major participants and future trends. It covers the diabetes therapeutics market in Indonesia.

Table of Contents

1. EXECUTIVE SUMMARY

Market Overview

  • Hepatitis B Therapeutics Executive Summary

2. HEPATITIS B THERAPEUTICS MARKET

Market Overview

  • Introduction
  • Context for the Study
  • Geographic Scope and Methodology
  • Restraints in Forecasts

3. INDONESIAN HEPATITIS B THERAPEUTICS MARKET

Market Overview

  • Introduction
  • Market Engineering Measurements
  • Government Initiatives

Market Forecasts and Trends

  • Patient Forecasts
  • Cost of Treatment
  • Treatment and Diagnosis
  • Clinical Trials

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis
  • Future Trends
  • Challenges Faced by Physicians

4. APPENDIX

Appendices Hepatitis B Indonesia

  • Total Population and Growth Rate
  • Access Population and Percent of Total Population
  • Carriers of HBV and Percent of Access Population
  • Total CHB Patients and Percent of Carriers of HBV
  • Diagnosed Patients and Percent of CHB Patients
Back to Top